Stocks and Investing
Stocks and Investing
Fri, January 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Patrick Trucchio Reiterated (ALT) at Strong Buy and Held Target at $50 on, Jan 20th, 2023
Patrick Trucchio of HC Wainwright & Co., Reiterated "Altimmune, Inc." (ALT) at Strong Buy and Held Target at $50 on, Jan 20th, 2023.
Patrick has made no other calls on ALT in the last 4 months.
There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 0 agree with Patrick's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Patrick
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Wednesday, January 18th, 2023
- Corinne Jenkins of "Goldman Sachs" Initiated at Strong Buy and Held Target at $20 on, Thursday, December 1st, 2022
- Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $26 on, Friday, November 11th, 2022
Contributing Sources